The bacterial lysate OM-85 reduces exacerbations and oral corticosteroid use in frequently exacerbating patients with T2-High asthma: The OMREXA real-world evidence study
This secondary post hoc analysis supports the therapeutic benefit of OM-85 in patients with T2-high asthma who have frequent exacerbations despite adherence to SoC asthma therapy.
Authors
- Lilia Panteli
- Ioannis Christopoulos
- Antonios Christopoulos
- John Moisidis
- Amalia Tryphonidou
- Maria Elpida Cristopoulou
Institutions
- University Medical Center Freiburg (DE)
- General University Hospital of Patras (GR)
- Asthma and Allergy Specialists (US)
Publication Details
- Journal
- Respiratory Medicine
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1016/j.rmed.2026.108695
- Primary Topic
- Pediatric health and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00